Study on X-Knife and Fractionated Radiotherapy in Patients with Primary Malignant Intracranial Neoplasms

王如密,陈苏,王守森,郑兆聪,李登锦,杨朋范,张锡增
DOI: https://doi.org/10.3969/j.issn.1009-7090.2002.01.013
2002-01-01
Abstract:Objective The survival benefit of combined X-knife radiosurgery and fractionated radiotherapy performed in 85 patients with primary malignant intracranial neoplasms were evaluated. Methods All of these patients had received initial X-knife therapy with a mean and median dose of 14~20Gy in 80% isodose. The fractionated radiotherapy was delivered by daily dose of 3.0~3.5 Gy, total dose of 20~40Gy/4~6 weeks. In some patients whole brain irradiation was delivered by dose level of 15~30Gy/3~4 weeks. Results The therapeutic effects were analysed at 3 months after X-knife radiotherapy. The effective rate was 73%(62/85) with tumor volume decreased more than 50%. Tumor recurrence or persistent growing occurred in 12 of the 62 patients. There were 22 of the 85 patients died. Conclusion The overall improvement of local control and prolong suvival period suggests that combined X-knife with ordinary fractionated radiotherapy is an effective and safe approach for treatment of malignant intracranial neoplasms.
What problem does this paper attempt to address?